![]() |
General |
American Society of Hematology Annual Meeting and Exposition |
| Several NCIC CTG abstracts will be presented at the 50th ASH Annual Meeting and Exposition
being held December 6-9, 2008 in San Francisco, California. Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: Long-term outcome of the EORTC 20981 phase III randomized intergroup study Marinus H.J. Van Oers, Martine Van Glabbeke, Liliana Baila, Livia Giurgia, Richard Klasa, Robert E Marcus, Max Wolf, Eva Kimby and Anton Hagenbeek. Tuesday, December 9, 2008: 8:00 AM NCIC CTG LY.7 http://ash.confex.com/ash/2008/webprogram/Paper6691.html The addition of rituximab eliminates the negative prognostic impact of PMBCL compared to DLBCL in young patients with CD20-positive aggressive lymphomas receiving a CHOP-like chemotherapy: Results of a subgroup analysis of the Mabthera International Trial Group (MInT) study Marek Trneny, Michael Rieger, Anders Osterborg, Ruth Pettengel, Darrell J White, Devinder Gill, Jan Walewski, MD, Evelyn Kuhnt, Markus Loeffler, Michael Pfreundschuh, and Anthony D. Ho. Tuesday, December 9, 2008: 8:45 AM NCIC CTG MY.9 http://ash.confex.com/ash/2008/webprogram/Paper9714.html Phase II testing of lenalidomide plus melphalan for previously untreated older patients with multiple myeloma: The NCIC CTG MY.11 trial Darrell J White, Nizar J Bahlis, Deborah C Marcellus, Andrew Belch, A. Keith Stewart, Christine Chen, Michael J Kovacs, David A Macdonald, Donna E Reece, Erica Harnett, Judy-Anne W Chapman, and Ralph M Meyer. Sunday, December 7, 2008, 6:00 PM-8:00 PM http://ash.confex.com/ash/2008/webprogram/Paper4160.html Tolerability and efficacy of bortezomib added to CVP-R for previously untreated advanced stage follicular lymphoma: Interim analysis of a phase II study by the NCIC Clinical Trials Group Laurie H Sehn, David A Macdonald, Sheldon H. Rubin, Morel Rubinger, Kevin R Imrie, Judy-Anne W Chapman, Marina Djurfeldt, Lois Shepherd, Stephen Couban, and Michael Crump. NCIC CTG LY.13 Saturday, December 6, 2008, 5:30 PM-7:30 PM http://ash.confex.com/ash/2008/webprogram/Paper13589.html 50th ASH Annual Meeting and Exposition December 6-9, 2008 Moscone Center San Francisco, CA http://www.hematology.org/meetings/2008/index.cfm |